Ashok Srivastava
ClinFomatrix, USA
Biography
Ashok Srivastava is a Chief Executive Officer and Chief Medical Officer of ClinFomatrix Oncology, USA. He was also the Founder and Chief Medical Officer of Global Pharmatek Clinical and Drug Safety Oncology, USA and Chief Medical Officer of CareBeyond - A Radiation Cancer Center in USA. He has more than 15 years of experience in drug development, medical affairs and commercialization of cancer drugs including radiopharmaceutical and supportive care. He is Leader in Cancer drug development worldwide large Phase-2 and 3 clinical trials in many countries. He has contributed to 21-INDs and 7-NDAs of Cancer Drugs and supportive care, acquisition /merger of company and drug for more than $300 million. He has published more than 85 papers in national and international journals, more than 120 abstracts, 3 book chapters and 2 patents. He is a leader in drug safety, pharmacovigilance of hematology, oncology drugs and built a global drug safety and pharmacovigilance companies in USA and India.
Abstract
Abstract : Challenges in breast cancer treatment and drug safety